A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction

Kaya E., Sikka S. C., GÜR S.

JOURNAL OF SEXUAL MEDICINE, cilt.12, sa.4, ss.856-875, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12 Sayı: 4
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/jsm.12828
  • Dergi Adı: JOURNAL OF SEXUAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.856-875
  • Anahtar Kelimeler: Metabolic Syndrome, Insulin Resistance, Obesity, Inflammation, Hypogonadism, Erectile Dysfunction, TESTOSTERONE REPLACEMENT THERAPY, HORMONE-BINDING GLOBULIN, PLASMINOGEN-ACTIVATOR INHIBITOR-1, CORONARY-ARTERY-DISEASE, TREATMENT PANEL-III, C-REACTIVE PROTEIN, QUALITY-OF-LIFE, INSULIN-RESISTANCE, HYPOGONADAL MEN, WEIGHT-LOSS
  • Ankara Üniversitesi Adresli: Evet

Özet

IntroductionMetabolic syndrome (MetS) is the most important public health issue threatening the health of men and women all over the world. Its current prevalence (i.e., approximately 30%) is continuously increasing. MetS by itself is considered a risk factor for erectile dysfunction (ED).